CyDex, Inc. Announces Second U.S. Approval of a Captisol-Enabled Prescription Anti-psychotic Drug
Schizophrenia Update, October 2002
OVERLAND PARK, Kan.,
CyDex announced the second U.S. approval of a Captisol-Enabled product -- Geodon for Injection (ziprasid>Early Schizophrenia Screening Test
General Schizophrenia Information